Inspire Medical Systems, Inc. (INSP)

62.99 +2.52% (+1.55)

Over 1M: +20.6%

Style
Area Line Line with markers Steps Candles Hollow candles Bars

Candles and bars need the day’s open, high and low, and need room to be drawn in: past about a year of trading a body is thinner than a hairline, so those three offer the longest window that fits instead.

55 60 65
3 Aug 6 Aug 11 Aug 14 Aug 19 Aug 24 Aug 27 Aug

Financials Quarterly

Figures
Revenue Gross Profit Operating Income Cost of Revenue Operating Cash Flow Free Cash Flow Net Income

A share count and earnings a share are not here: neither is money, so neither can share this axis. Both have their own panel on All charts.

All charts ›
Q3 '21 — Revenue: 61.7M Q4 '21 — Revenue: 78.4M Q1 '22 — Revenue: 69.4M Q2 '22 — Revenue: 91.4M Q3 '22 — Revenue: 109.2M Q4 '22 — Revenue: 137.9M Q1 '23 — Revenue: 127.9M Q2 '23 — Revenue: 151.1M Q3 '23 — Revenue: 153.3M Q4 '23 — Revenue: 192.5M Q1 '24 — Revenue: 164M Q2 '24 — Revenue: 195.9M Q3 '24 — Revenue: 203.2M Q4 '24 — Revenue: 239.7M Q1 '25 — Revenue: 201.3M Q2 '25 — Revenue: 217.1M Q3 '25 — Revenue: 224.5M Q4 '25 — Revenue: 269.1M Q1 '26 — Revenue: 204.6M Q2 '26 — Revenue: 200.6M 0 60M 120M 180M 240M 300M
Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26
Revenue

Figures as at 2026-06-30, reported in USD. The newest fact in the filings is dated 2026-06-30, 61 days ago. Nothing on this page is advice.

How it scores

Five questions, each answered by the measures under it. Every figure is the company's own; the bar beside it is where that figure sits among the companies read here — the top fifth, the bottom fifth, or somewhere between. Not among all listed companies, and for a valuation multiple the low end is the good end.

Quality

How much of the revenue is really kept — and what did it take to earn it?

2.6
SBC / sales 13.3%
ROIC 8.5%
OE margin -0.26%
Accruals -2.4%
Gross margin 86.1%
OCF / EBIT 2.9×
ROA 14.6%
FCF margin 13.0%
OCF margin 17.5%
ROE 16.4%
ROCE 6.3%

5 of 17 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Valuation

What does the price ask for what the company earns, owns and pays out?

0.5
Div. yield —
EV/EBIT —
EV/GP —
EV/OE —
EV/Sales —
FCF yield —
Fwd P/E —
P/B —
P/C —
P/E —
PEG —

0 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Durability

How predictable is the revenue, and how much of it is already committed?

6.8
RPO / sales —
RPO growth —
Segment HHI —

3 of 7 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Resilience

Can the balance sheet absorb a bad year?

9.7
Interest cover 353.7×
ND/EBITDA —
Debt / Eq 0.0×
Debt payback 0.0 yr
Payout 0.0%
Quick ratio 6.2×
F-score 6.8 pts
Cash / Debt —
Cash runway —

3 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Growth

Is the business getting bigger, and is it getting more profitable?

6.0
Sales CAGR 4Y +40.6%
Sales/sh Y/Y +7.1%
EPS Y/Y +160.9%
EBIT Y/Y +30.7%
Sales Q/Q -7.6%
Div. growth —
EBIT CAGR —
EPS CAGR 4Y —
EPS next Y —

4 of 13 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

A measure absent from a block could not be computed from this company's filings. It is left out rather than scored as though it were bad, and the dimension is averaged over what remains. A score is measured against a fixed scale this model states; the bar is measured against the other companies, so the two can disagree — and where they do, that disagreement is the more interesting figure.